Deciphera Pharmaceuticals

We’re presenting at #ESMO25! Join us in Berlin for our poster presentation on the long-term safety and efficacy results of our Phase 3 MOTION trial of vimseltinib. To read the full results, visit: https://lnkd.in/en2qVCtC   #CancerResearch #TGCT

Happy #CertificationNationDay! We are proud to be a part of the Great Place To Work community. Hear directly from our team members why they think Deciphera is a #GreatPlaceToWork. Interested in joining our team? Visit: https://lnkd.in/eVxsxaq7

Last week, we brought together the global Deciphera team for a gathering focused on collaboration and collective impact. We discussed our shared goals, celebrated recent wins, and looked ahead to near-term opportunities. From Germany to Switzerland, Kansas to Waltham, and as far as Japan, it was great to all be together as we further our mission of delivering transformational medicines to patients.

Our Chief Commercial Officer, Margarida Duarte, will participate in a panel during the Zug Pharma Group 2025 Zug Life Science Summit this week! During the event, Ms. Duarte will share her perspective on her visions for the #lifesciences industry in Zug.    Learn more: https://lnkd.in/eQm9GMHs    #ZugSummit25 

#DidYouKnow that nearly 1 in 4 cancer diagnoses is rare? September 30th marks #RareCancerDay, an annual awareness day devoted to shining a light on rare cancers like #GIST. Learn more about the National Organization for Rare Disorders and the Rare Cancer Day initiative here: https://lnkd.in/eh2gwb8J

Our Lawrence, KS office is growing! We’re seeking a Director of Biological Sciences to join our oncology #drugdiscovery group. If you’re collaborative, driven, and a strategic problem-solver, apply here: https://lnkd.in/eBK9bg4J #Hiring #PharmaJobs

Behind our extensive oncology pipeline is a talented group of scientists, clinicians, and researchers dedicated to delivering transformational medicines that have a meaningful impact on patients. We’re excited about what we’ve achieved so far in #cancerresearch, and look forward to continuing to raise the bar for patients in #oncology. #WorldCancerResearchDay Learn more about our work: https://www.deciphera.com/

We are excited about the recent European Commission approval of our new medicine for people living with tenosynovial giant cell tumor (#TGCT)! Learn more: https://lnkd.in/ed5zs6sQ #CancerResearch

We’re proud to announce the European Commission approval of our medicine for patients with symptomatic tenosynovial giant cell tumor (#TGCT) associated with clinically relevant physical function deterioration and in whom surgical options have been exhausted or would induce unacceptable morbidity or disability. Learn more at our press release here: https://lnkd.in/ed5zs6sQ

Are you a clinical supply chain expert with experience in leading a team? We’re looking for a Director of Clinical Supply Chain to join us in Waltham and aid in our mission to deliver transformational medicines to patients. Read the full job description here: https://lnkd.in/eBK9bg4J #Hiring #SupplyChain #PharmaJobs